Table 2 A summary of antibiotic usage between the flare and non-flare populations.
Antibiotic group | Non-flare patients | Flare patients | |
|---|---|---|---|
Antibiotic usage (at least one prescription [%]) | Beta-lactam | 61.29% | 76.01% |
Imidazole | 8.56% | 11.99% | |
Macrolide | 33.15% | 49.07% | |
Nitrofurantoin | 12.31% | 19.20% | |
Quinolone | 14.02% | 21.48% | |
Sulphonamide and Trimethoprim | 24.75% | 32.21% | |
Tetracycline | 19.52% | 28.27% | |
Antibiotic usage (total DDD’s [+/− SD]) | Beta-lactam | 46.29 (+/− 137.41) | 62.07 (+/− 134.11) |
Imidazole | 12.23 (+/− 16.04) | 11.23 (+/− 12.72) | |
Macrolide | 31.17 (+/− 91.43) | 35.47 (+/− 102.81) | |
Nitrofurantoin | 42.93 (+/− 185.45) | 60.71 (+/− 243.65) | |
Quinolone | 24.49 (+/− 80.50) | 27.71 (+/− 83.52) | |
Sulphonamide and Trimethoprim | 29.91 (+/− 156.68) | 28.33 (+/− 97.17) | |
Tetracycline | 58.26 (+/− 242.83) | 56.50 (+/− 177.54) |
